Guanze Medical Information Industry (Holding) Co., Ltd., commonly referred to as Guanze Group, is a prominent player in the healthcare sector, headquartered in China. Established in 2001, the company has made significant strides in medical information services, focusing on areas such as healthcare data management, clinical research, and medical consulting. With a strong operational presence across various regions in Asia, Guanze Group is renowned for its innovative solutions that enhance healthcare delivery and patient outcomes. The company’s core offerings include advanced medical information systems and comprehensive data analytics, setting it apart in a competitive market. Recognised for its commitment to quality and excellence, Guanze Group has achieved notable milestones, solidifying its position as a trusted partner in the medical information industry.
How does Guanze Medical Information Industry (Holding) Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Guanze Medical Information Industry (Holding) Co., Ltd.'s score of 15 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Guanze Medical Information Industry (Holding) Co., Ltd. reported an emissions intensity of approximately 0.0005 tonnes CO2e per unit of revenue, based on a revenue of about USD 25,678,826. This figure reflects the company's operational impact but does not specify total emissions in terms of Scope 1, 2, or 3, as no absolute emissions data has been disclosed. For 2021, the emissions intensity was approximately 0.00037 tonnes CO2e per unit of revenue, with a revenue of about USD 33,226,709. Again, specific emissions figures were not provided, indicating a lack of detailed reporting on carbon emissions. Currently, Guanze Medical does not have any publicly stated reduction targets or commitments under initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. The absence of these commitments suggests that the company may be in the early stages of developing a comprehensive climate strategy. As of now, there is no data cascaded from a parent or related organization, indicating that Guanze Medical's emissions reporting is independent. The company is encouraged to enhance its transparency and set measurable targets to align with global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guanze Medical Information Industry (Holding) Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
